Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and PanelsNSE:SAAKSHI -1.43%50 Piotroski F-Score is 6 as of Sep. 12, 2026, which is at its 10-year median of 6.00. GuruFocus rates NSE:SAAKSHI with a GF Score™ of 50/100 and a GF Value™ of ₹220.57 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 3,012 Industrial Products companies, Saakshi Medtech and Panels ranks better than 75.3% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Saakshi Medtech and Panels has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Saakshi Medtech and Panels's Piotroski F-Score or its related term are showing as below:
NSE:SAAKSHI'
s Piotroski F-Score Range Over the Past 10 Years
Min: 5 Med: 6 Max: 9
Current: 6
During the past 7 years, the highest Piotroski F-Score of Saakshi Medtech and Panels was 9. The lowest was 5. And the median was 6.
Saakshi Medtech and Panels (NSE:SAAKSHI) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Saakshi Medtech and Panels Piotroski F-Score Related Terms
Saakshi Medtech and Panels Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saakshi Medtech and Panels Piotroski F-Score Chart
NSE:SAAKSHI vs VRT, BE: Piotroski F-Score Comparison
For the Electrical Equipment & Parts subindustry, Saakshi Medtech and Panels's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saakshi Medtech and Panels Piotroski F-Score vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Saakshi Medtech and Panels's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Saakshi Medtech and Panels's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Saakshi Medtech and Panels's current Net Income (TTM) was 122.9.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Saakshi Medtech and Panels's current Cash Flow from Operations (TTM) was 175.8.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Saakshi Medtech and Panels's return on assets of this year was 0.09357613. Saakshi Medtech and Panels's return on assets of last year was 0.03604203.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Saakshi Medtech and Panels's gearing of this year was 0.11194645. Saakshi Medtech and Panels's gearing of last year was 0.10722766.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Saakshi Medtech and Panels's current ratio of this year was 2.05652404. Saakshi Medtech and Panels's current ratio of last year was 2.92330288.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Saakshi Medtech and Panels's number of shares in issue this year was 17.658. Saakshi Medtech and Panels's number of shares in issue last year was 17.64.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Saakshi Medtech and Panels's gross margin of this year was 0.443907. Saakshi Medtech and Panels's gross margin of last year was 0.39774491.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Saakshi Medtech and Panels's asset turnover of this year was 0.8794879. Saakshi Medtech and Panels's asset turnover of last year was 0.70733467.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
0
+
0
+
0
+
1
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Saakshi Medtech and Panels has an F-score of 6 indicating the company's financial situation is typical for a stable company.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a Piotroski F-Score of 6 as of Sep. 12, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Saakshi Medtech and Panels and its competitors. This is near median its historical median of 6.00. Over the past decade, Saakshi Medtech and Panels' Piotroski F-Score has ranged from 5.00 to 9.00. According to the industry distribution chart, Saakshi Medtech and Panels ranks #744 out of 3012 companies in the Industrial Products industry, placing it in the top 24.7%.
Is Saakshi Medtech and Panels' Piotroski F-Score too high?
Saakshi Medtech and Panels' current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 9.00. The Industrial Products industry median Piotroski F-Score is 5.00. Saakshi Medtech and Panels' value of 6 is 20% above this industry median. Based on the distribution chart, Saakshi Medtech and Panels ranks #744 out of 3012 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' Piotroski F-Score compare to VRT and BE?
According to the Industrial Products industry distribution chart, Saakshi Medtech and Panels ranks #744 out of 3012 companies for Piotroski F-Score. This places Saakshi Medtech and Panels in the top 25% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Saakshi Medtech and Panels' value of 6 is 20% above this benchmark. Historically, Saakshi Medtech and Panels' own Piotroski F-Score has ranged from 5.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Saakshi Medtech and Panels has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Industrial Products company?
The median Piotroski F-Score among Industrial Products companies is 5.00, based on 3,012 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saakshi Medtech and Panels's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Saakshi Medtech and Panels and its competitors. For the Industrial Products industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saakshi Medtech and Panels's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Industrial Products industry median of 5.00. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current Piotroski F-Score is 6 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
Piotroski F-Score: 6 (near median its 10-year median of 6.00)
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
Industry Position: 20% above the Industrial Products median (#744 of 3012)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
